The articles listed on this page are from a variety of sources. 
1. The staff of DBS-STN often attends conferences or educational opportunities both nationally and internationally, and a brief understandable write-up of the information presented at the event will be provided for our readers to review. 
2. DBS-STN staff also identifies or writes various articles related to topics that are thought to be of interest for the reader of www.DBS-STN.org. 

Browse by Topic:
Search:

Parkinson’s Study Dims Ambitions for Gene Flaw Carried by Brin


(February 9, 2015) - Two experimental drugs for Parkinson’s disease have caused lung toxicity in monkeys, researchers said, delivering a setback to one of the most promising pathways to a new type of treatment for Parkinson’s disease - a drug that interferes with a compound called leucine-rich repeat kinase 2 (LRRK2). Mutations in the gene that produces LRRK2 have been linked with Parkinson's disease. The LRRK2 gene mutation gained attention after Sergey Brin, co-founder of Google Inc., disclosed in 2008 that his genetic code carries the mutation. Read more…



Article Archive

back